Oramed Pharma
ORMP----
Forecast & RatingOnly 1 analyst currently covers Oramed Pharma (ORMP.US), with a price target of $7.00. The sample is very small, so treat this as a reference only. Data as of Aug 31, 2026; this does not constitute investment advice.
Aug 28, 2026Price forecast
$7.0071.57%
Forecast & Rating-
Target price forecast
Forecast dateOct 26, 2026
Forecast met36.5%
Stock price$4.08
Avg. target$7.0
High target$7
Low target$7
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.